IDEAYA Biosciences (IDYA) Operating Margin: 2020-2025
Historic Operating Margin for IDEAYA Biosciences (IDYA) over the last 3 years, with Sep 2025 value amounting to 52.18%.
- IDEAYA Biosciences' Operating Margin was N/A to 52.18% in Q3 2025 from the same period last year, while for Sep 2025 it was -73.86%, marking a year-over-year change of. This contributed to the annual value of -4,671.07% for FY2024, which is 409622.00% down from last year.
- Per IDEAYA Biosciences' latest filing, its Operating Margin stood at 52.18% for Q3 2025, which was up 102.53% from -2,059.11% recorded in Q4 2024.
- IDEAYA Biosciences' 5-year Operating Margin high stood at 52.18% for Q3 2025, and its period low was -2,059.11% during Q4 2024.
- Over the past 3 years, IDEAYA Biosciences' median Operating Margin value was -670.02% (recorded in 2023), while the average stood at -791.54%.
- As far as peak fluctuations go, IDEAYA Biosciences' Operating Margin surged by 13,271bps in 2022, and later tumbled by 99,035bps in 2024.
- IDEAYA Biosciences' Operating Margin (Quarterly) stood at -620.16% in 2021, then crashed by 3,730bps to -657.46% in 2022, then slumped by 41,131bps to -1,068.77% in 2023, then slumped by 99,035bps to -2,059.11% in 2024, then reached 52.18% in 2025.
- Its Operating Margin was 52.18% in Q3 2025, compared to -2,059.11% in Q4 2024 and -1,068.77% in Q4 2023.